InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 12.84 CNY -3.75% Market Closed
Market Cap: 10.8B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

InnoCare Pharma Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InnoCare Pharma Ltd
Cash Equivalents Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
InnoCare Pharma Ltd
SSE:688428
Cash Equivalents
ÂĄ4.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InnoCare Pharma Ltd's Cash Equivalents?
Cash Equivalents
4.6B CNY

Based on the financial report for Dec 31, 2022, InnoCare Pharma Ltd's Cash Equivalents amounts to 4.6B CNY.

What is InnoCare Pharma Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 1Y
67%

Over the last year, the Cash Equivalents growth was 67%.

Back to Top